Screening designs for drug development
From MaRDI portal
Recommendations
Cited in
(10)- Bayesian designs and the control of frequentist characteristics: a practical solution
- Bayesian Optimal Design for Phase II Screening Trials
- Statistical methodology for screening studies with qualitative/quantitative mixtures
- Decision-theoretic designs for a series of trials with correlated treatment effects using the Sarmanov multivariate beta-binomial distribution
- Phase 2 and 3 Combination Designs to Accelerate Drug Development
- A Review of Modern Computational Algorithms for Bayesian Optimal Design
- Bayes Optimal Informer Sets for Early-Stage Drug Discovery
- A Comparative Tutorial of Bayesian Sequential Design and Reinforcement Learning
- The performance of fixed-horizon, look-ahead procedures compared to backward induction in Bayesian adaptive-randomization decision-theoretic clinical trial design
- Building efficient comparative effectiveness trials through adaptive designs, utility functions, and accrual rate optimization: finding the sweet spot
This page was built for publication: Screening designs for drug development
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q5308154)